ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology

June 28, 1996

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

As Sequestration Hits: Varmus on Living in “Pretty Awful Times”

June 26, 2013

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979